Back
Eli Lilly and Vs. Intra-Cellular Therapies Industry Stock Comparison
Buy
56
LLY
Eli Lilly and
Last Price:
781.21
Seasonality Move:
3.51%
Sell
37
ITCI
Intra-Cellular Therapies
Last Price:
71.85
Seasonality Move:
4.56%
Buy
56
Eli Lilly and (LLY)
is a Buy
Is Eli Lilly and a Buy, Sell or Hold?
- The current Eli Lilly and [LLY] share price is $737.20. The Score for LLY is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- LLY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy, Sell or Hold?
- The current Intra-Cellular Therapies [ITCI] share price is $72.30. The Score for ITCI is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- ITCI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $737.20
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LLY is experiencing slight buying pressure.
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $72.30
The current trend is moderately bullish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.
LLY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -7.51 | Sell |
Relative Strength Index (14 RSI): | 44.74 | Sell |
Chaikin Money Flow: | 1022274 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (737.93 - 773.27) | Sell |
Bollinger Bands (100): | (620.69 - 772.55) | Buy |
ITCI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.38 | Buy |
Relative Strength Index (14 RSI): | 53.26 | Buy |
Chaikin Money Flow: | -346308 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (66.59 - 73.79) | Buy |
Bollinger Bands (100): | (65.08 - 72.16) | Buy |
LLY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 734.63 | Buy |
20-day SMA: | 751.27 | Sell |
50-day SMA: | 760.93 | Sell |
200-day SMA: | 624.12 | Buy |
8-day EMA: | 737.01 | Buy |
20-day EMA: | 746.31 | Sell |
50-day EMA: | 740.97 | Sell |
200-day EMA: | 633.57 | Buy |
ITCI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 72.98 | Sell |
20-day SMA: | 70.61 | Buy |
50-day SMA: | 69.4 | Buy |
200-day SMA: | 62.33 | Buy |
8-day EMA: | 72.67 | Sell |
20-day EMA: | 71.32 | Buy |
50-day EMA: | 69.65 | Buy |
200-day EMA: | 64.15 | Buy |
Eli Lilly and Earnings Growth & LLY Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.58 per share, an increase next quarter of $0.02 per share, an increase this year of $6.18 per share, and an increase next year of $5.66 per share.
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.07 per share, an increase this year of $0.98 per share, and an increase next year of $1.45 per share.
Eli Lilly and Technical Analysis
Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Intra-Cellular Therapies Technical Analysis
Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |